Phase II study of multimodaility therapy in mantle cell lymphoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Busulfan; Cyclophosphamide; Cytarabine; Doxorubicin; Interferon alpha; Interleukin-2; Methotrexate; Prednisone; Teniposide; Vincristine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 06 Jun 2012 Biomarkers information updated
- 17 Feb 2011 Actual end date (Aug 2006) added as reported by ClinicalTrials.gov.
- 17 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.